Company news
Global Hemp Group, Inc. news in 2023
Global Hemp Group, Inc.'s news releases, calls and decks from 2023, newest first.
Global Hemp Group Concludes First U.S. Sublicense Related to Its Recently Acquired Exclusive North American License of Apollon Formularies IP
April 28, 2023
Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property
April 4, 2023
Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor
March 30, 2023
Global Hemp Group Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at MD Anderson Cancer Center, as Its Chief Scientific Advisor
March 22, 2023
Global Hemp Group Adds Israel, the European Union and Morocco as Exclusive Global Licenses from Apollon Formularies, PLC
March 21, 2023
Global Hemp Group Announces Stephen D. Barnhill Jr. Has Been Appointed Interim President & CEO
March 20, 2023
Global Hemp Group Welcomes Mathieu Couillard and the Continuing Engagement of Twilight Capital on Its Advisory Board
February 17, 2023
Global Hemp Group Announces the Appointment of Arelio Useche and Veronique Laberge to the Company's Board of Directors
February 14, 2023
Global Hemp Group Announces Execution of Exclusive Licensing Agreement for the Intellectual Property of Apollon Formularies PLC Covering the United States, Canada, and Mexico
January 23, 2023
Global Hemp Group Announces Execution of Binding LOI with Apollon Formularies PLC
January 11, 2023